Edit |   |
---|---|
Antigenic Specificity | IGHE, Human (Tanezumab biosimilar) |
Clone | Tanezumab |
Host Species | Recombinant Mouse |
Reactive Species | human |
Isotype | IgG1 |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | ELISA, FuncS, Inhib |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human IGHE Recombinant Antibody (Tanezumab). Tanezumab (INN, codenamed RN624) is a monoclonal antibody against nerve growth factor as a treatment for pain. Tanezumab was discovered and developed by Rinat Neuroscience and was acquired by Pfizer in 2006. |
Immunogen | n/a |
Other Names | Anti-IGHE Recombinant Antibody, Research Grade Tanezumab, Anti-Human IGHE Recombinant Antibody(Tanezumab), PF-04383119, RN624, Antibody Drug Analogues, Monoclonal Antibody, YR1147, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 880266-57-9 |
Catalog # | YR1147 |
Price | please inquire |
Order / More Info | IGHE, Human (Tanezumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |